OLIVER HEINLE: Open Payments
NPI 1942283460 · ALPHARETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,380 in 74 payments from 21 companies in 2025. Trend: 2023 $1,515 · 2024 $1,592 · 2025 $1,380
Food & beverage: $1,380
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $211 |
| Novo Nordisk Inc | 10 | $188 |
| ABBVIE INC. | 11 | $178 |
| Lilly USA, LLC | 9 | $133 |
| SANOFI-AVENTIS U.S. LLC | 6 | $128 |
| Abbott Laboratories | 4 | $82 |
| Amgen Inc. | 4 | $70 |
| Eisai Inc. | 2 | $57 |
| Noven Therapeutics, LLC | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
Products named: Veozah, TZIELD, Ozempic, QULIPTA, ZEPBOUND, FREESTYLE LIBRE 3, Leqembi, EVENITY.
Industry payments across GA — which companies pay providers there.
